Webull Securities South Africa (Pty) Ltd (Webull SA) is authorised and regulated by the Financial Sector Conduct Authority (in South Africa) as an authorised financial services provider (FSP No 50863). South African residents must obtain the necessary tax clearance certificates to use their foreign investment allowance when funding their international investment account.
International financial products and services are offered to self-directed clients by Webull Securities (Australia) Pty Ltd (Webull Securities Australia) ABN: 51 654 849 457. Webull Securities Australia is the holder of an Australian Financial Services Licence (AFSL Number 536980) issued by the Australian Securities and Investments Commission.
Market data, development, and operations of this website are provided by Webull Technologies Pte. Ltd (Webull).
Webull SA, Webull Securities Australia and Webull are separate entities under common ownership.
No content on this website or affiliated websites/applications should be considered a recommendation or solicitation for the purchase or sale of securities, derivatives, or any other financial products.
All information and data contained in this website are for reference only, and no historical data should be considered as the basis for predicting future trading trends. Investors should be aware that system responses, execution price, speed, liquidity, market data, and account access times may be affected by many factors, including market volatility, size and type of order, market conditions, system performance and other factors.
The information provided is for informational purposes only unless otherwise stated. Distribution of investment products to, or services offered to, any person is not intended in any jurisdiction where such distribution or use would contravene prevailing laws or regulations. Services are only intended for persons in jurisdictions or countries where it is legal for such persons to receive them.
All investments involve risks and are not suitable for every investor. The value of securities may fluctuate, and as a result clients may lose more than their original investment. Margin trading increases the risk of loss and clients’ losses may exceed the deposits paid. The past performance of a security or financial product does not guarantee future results or returns. Please bear in mind that while diversification may help spread risk, it does not assure a profit or protect against loss in a down market. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing.
Options trading involves significant risk and is not suitable for all investors as investors may be exposed to potentially rapid and substantial losses. Options trading functionality is subject to Webull AU’s review and approval. Please read the Characteristics and Risks of Standardized Options before investing in US options.
Relevant regulatory and exchange fees may apply. Please refer to our Fee Schedule for more details.
Please note that the information contained on this website must not be copied, modified, published, distributed, or reproduced in whole or in part without the prior written consent of Webull. Where hyperlinks are available to a third-party website/application they are independent of Webull and the use of such links is at your own risk.
Webull accepts no responsibility and shall not be liable for any loss or damage caused by or in connection with the use of or reliance on any content, goods, or services available on or through any third-party website/application.
The content on this website may be translated into other languages. Where such a translation is made, this English version remains definitive. If there are any discrepancies between the English version and any version of the content in another language, the English version shall prevail.
Copyright © 2026 Webull Securities South Africa (Pty) Ltd. All Rights Reserved.
View original content to download multimedia:https://www.prnewswire.com/news-releases/armata-pharmaceuticals-to-participate-in-the-hc-wainwright-28th-annual-global-investment-conference-302873826.html